Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization to Accelerate Future Liver Remnant (FLR) Hypertrophy

NCT04272931 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.

NCT NCT04272931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04272931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization to Accelerate Future Liver Remnant (FLR) Hypertrophy
Lead sponsor
Maastricht University
Phase
Not applicable
Overall status
Unknown status
Start date
May 8, 2020
Completion date
December 31, 2023
Enrollment
111 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer liver metastases